Liz joined HERC in February 2018, from the Centre for the Advancement of Sustainable Medical Innovation (CASMI) - a policy research group in Oxford’s Radcliffe Department of Medicine. Her work focused on the health economics of cancer drugs, exploring the impact of technology appraisal processes on patient access to drugs, and the value that society places on treating cancer relative to other conditions.
Before joining CASMI, Liz worked as a freelance researcher with clients in pharmaceuticals and education, and as a product development manager in consumer healthcare.
Liz is working with Sarah Wordsworth and colleagues, initially on a series of Discrete Choice Experiments exploring clinician and public attitudes to antibiotics and antimicrobial resistance.
Preferences for Medical Consultations from Online Providers: Evidence from a Discrete Choice Experiment in the United Kingdom
BUCHANAN J. et al, (2021), Applied Health Economics and Health Policy
Implementing interventions to reduce antibiotic use: A qualitative study in high-prescribing practices
BOREK A. et al, (2021), BMC Family Practice
Awareness of appropriate antibiotic use in primary care for influenza-like illness: evidence of improvement from UK population-based surveys
POUWELS K. et al, (2020), Antibiotics
Delayed antibiotic prescription by general practitioners in the UK: a stated-choice study
MORRELL E. et al, (2020), Antibiotics
How did a Quality Premium financial incentive influence antibiotic prescribing in primary care? Views of Clinical Commissioning Group and general practice professionals
BOREK A. et al, (2020), Journal of Antimicrobial Chemotherapy